RESCUE-HF Trial: Retrograde Delivery of Allogeneic Umbilical Cord Lining Subepithelial Cells in Patients with Heart Failure
Cell therapy is an evolving option for patients with end-stage heart failure. First-generation cell therapy trials have had marginal success. Our goal was to evaluate retrograde delivery of allogeneic umbilical cord subepithelial cells (UCSECs) in patients with heart failure. A prospective open-labe...
Main Authors: | Jorge Tuma, Antonio Carrasco, Jorge Castillo, Carlos Cruz, Alvaro Carrillo, Jose Ercilla, Carlos Yarleque, Jaime Cunza, Courtney E. Bartlett, Amalia A. Winters, Francisco J. Silva, Amit N. Patel M.D., M.S. |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2016-09-01
|
Series: | Cell Transplantation |
Online Access: | https://doi.org/10.3727/096368915X690314 |
Similar Items
-
Safety and feasibility of percutaneous retrograde coronary sinus delivery of autologous bone marrow mononuclear cell transplantation in patients with chronic refractory angina
by: Ercilla Jose, et al.
Published: (2011-10-01) -
Mesenchymal Stem Cell Population Isolated from the Subepithelial Layer of Umbilical Cord Tissue
by: Amit N. Patel M.D., M.S., et al.
Published: (2013-03-01) -
An Incidental Subepithelial Cecal Lesion
by: José Pedro Rodrigues, et al.
Published: (2018-02-01) -
Endoscopic Treatment of Subepithelial Tumors
by: Su Young Kim, et al.
Published: (2018-01-01) -
The Pathologic Confirmation in Subepithelial Tumors
by: Kwan Hong Lee, et al.
Published: (2021-09-01)